Relevant Issues of Planning Bioequivalence Studies of Drugs with a Narrow Therapeutic Range
In order to be registered, generic drugs with a narrow therapeutic range have to undergo bioequivalence or therapeutic equivalence studies. In most cases, comparative pharmacokinetic studies and demonstration of bioequivalence between the test and the reference products are sufficient for this group...
Saved in:
| Main Author: | D. P. Romodanovsky |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2020-09-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/315 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A COMPARATIVE ANALYSIS OF BIOEQUIVALENCE, CLINICAL EFFICACY AND SAFETY OF GENERIC VERSUS ORIGINAL CYCLOSPORINE AFTER KIDNEY TRANSPLANTATION
by: E. S. Stolyarevich, et al.
Published: (2015-04-01) -
Risk of Serious Skin Rash with Antiepileptic Drugs
by: J Gordon Millichap
Published: (1997-09-01) -
On the interchangeability of calcineurine inhibitors
by: K. E. Zatolochina, et al.
Published: (2018-02-01) -
Drug interchangeability: Clinical efficacy and safety
by: S. K. Zyryanov, et al.
Published: (2017-06-01) -
Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)